BamSEC and AlphaSense Join Forces
Learn More

Urovant Sciences Ltd. – Material Contracts

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 10-Q 4 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed Amendment No. 2 to Market Access Services Agreement
12/34/56
EX-10.2
from 10-Q 10 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed Amendment No. 1 to Market Access Services Agreement
12/34/56
EX-10.1
from 10-Q 31 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed Co-Promotion Agreement
12/34/56
EX-10.1
from 8-K 15 pages Voting and Support Agreement
12/34/56
EX-10.1
from DEFA14A 15 pages Voting and Support Agreement
12/34/56
EX-10.1
from 10-Q 34 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Market Access Services Agreement
12/34/56
EX-10.22
from 10-K 20 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 29 pages Information Sharing and Cooperation Agreement by and Among Urovant Sciences Ltd., and Sumitovant Biopharma Ltd. Dated as of May 21, 2020
12/34/56
EX-10.1
from 8-K 16 pages Urovant Sciences Ltd. Indemnification Agreement
12/34/56
EX-10.2
from 8-K 22 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 15 pages Confidential Separation Agreement, General Release and Consulting Agreement
12/34/56
EX-10.2
from 8-K 40 pages Investor Rights Agreement Dated as of December 27, 2019 by and Among Urovant Sciences Ltd., Sumitovant Biopharma Ltd. and Sumitomo Dainippon Pharma Co., Ltd
12/34/56
EX-10.2
from 8-K 20 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 4 pages Sumitomo Dainippon Pharma, Co. Ltd
12/34/56
EX-10.2
from 8-K 19 pages Urovant Sciences Ltd. 2017 Equity Incentive Plan, as Amended and Restated
12/34/56
EX-10.1
from 8-K 12 pages Urovant Sciences Ltd. 2019 Employee Stock Purchase Plan Adopted by the Board of Directors: July 9, 2019 Approved by the Shareholders: September 12, 2019
12/34/56
EX-10.1
from 10-Q 23 pages Sublease Between Roivant Sciences, Inc
12/34/56
EX-10.24
from 10-K 9 pages Unconditional Secured Guaranty Section 1 – Guarantee
12/34/56
EX-10.1
from 10-Q 8 pages Urovant Sciences Ltd. Restricted Stock Unit Grant Notice
12/34/56
EX-10.21
from S-1/A 20 pages Executive Employment Agreement
12/34/56